Cipla

The company said it has received final approval for Lanreotide Injection from the US Food and Drug Administration (FDA)

The company will invest up Rs six crores for the 33 per cent stake in the target firm

Spirofy is India's first pneumotach-based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder…

The Emerging Markets Index for the year comprises 108 companies from 12 emerging economies, including China, Brazil, South Africa…

Cipla has announced its unaudited consolidated financial results for quarter ended September 30th, 2021. Key highlights of…

While Samir Mehta, Chairman, Torrent Group, has been appointed as the President of IPA for 2021-2023, Samina Hamied, Executive…

As part of this agreement, Lilly will transfer its rights in India to sell, promote and distribute the aforesaid two Lilly…

Experts share insights on how simulation and modelling can bring significant benefits to the pharma sector such as process…

The collaboration was established after a study of over 1,100 pharmacists titled Future of Pharmacies, conducted by the two…

According to IQVIA (IMS Health), Durezol had US sales of around $106 million for the 12-month period ending June 2021